GlassScriptPhysician profile
Sridhar Bhaskara
NPI 1003892035
$3,233.32
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,484 · 2020: $123 · 2021: $139 · 2022: $221 · 2023: $181 · 2024: $84.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $265.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,415.57 | 2019-2020 | |
| Stimwave Technologies Incorporated | $424.86 | 2019 | |
| Abbvie INC. | $348.31 | 2022-2024 | Botox |
| Nevro Corp. | $246.01 | 2019-2022 | |
| Tersera Therapeutics LLC | $243.69 | 2019-2021 | |
| Boston Scientific Corporation | $162.44 | 2019 | |
| Medtronic, INC. | $116.11 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $66.20 | 2019 | |
| Pfizer INC. | $48.55 | 2019-2020 | |
| Allergan, INC. | $32.52 | 2021 | |
| Flowonix Medical Incorporated | $31.86 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $30.60 | 2021 | |
| Amgen INC. | $29.80 | 2020 | |
| Ge Healthcare | $19.72 | 2022 | |
| Chiesi USA, INC. | $17.08 | 2024 | Cleviprex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sridhar Bhaskara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.